• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Stephen Lott, PharmD, MS

Latest:

Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management

The high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.


Dhruv Chopra, MS

Latest:

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.


Jessica Allegretti, MD, MPH

Latest:

Looking Toward the Future: Management of C. Diff Infection

Closing out their discussion on recurrent clostridium difficile infection management, experts share closing thoughts and hopes for the future.


Elliot B. Tapper, MD

Latest:

Baffled by NAFLD: The Horse Might Be Out of the Barn but Should Not Take Us for a Ride

As awareness of nonalcoholic fatty liver disease (NAFLD) rises, it is essential to develop and implement a rigorously determined approach to identify patients who will, or will not, benefit from diagnostic evaluation.


Jennifer L. Bright, MPA

Latest:

Overhauling Quality Measurement in the US: Measure What Matters

As the US charts its course through the next political era, it is crucial that we boldly allocate resources and prioritize what truly impacts patients. When faced with complexity, feasibility concerns, or entrenched norms, we must proclaim: “It’s the outcomes, stupid.”


Meena Venkatachalam, MSc

Latest:

Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes

Jason Shafrin, PhD, serves as the vice president of Health Economics at PRECISIONheor, and Meena Venkatachalam, MSc, is the senior director of Health Economics at PRECISIONheor.


Alison Galbraith, MD, MPH

Latest:

Impact of the COVID-19 Pandemic on Regular Emergency Department Users

Regular users of the emergency department (ED) transiently reduced ED visits when faced with ED access barriers during the COVID-19 pandemic.


Kaitlyn Bader

Latest:

Addressing the Psychosocial Impacts of Inflammatory Skin Conditions in Patient Care

Lauren Miller, PA-C, kicked off the inaugural 2023 Inflammatory Disease Summit by discussing the psychosocial impacts related to atopic dermatitis, psoriasis, and hidradenitis suppurativa.


Areeba Kara, MD

Latest:

Inpatient Opioid Receipt and Care Experiences for Vaginal Delivery

The objective of this study was to examine the relationship between inpatient opioid receipt and care experiences of women hospitalized for vaginal delivery.


Matthew Collins, MD, MBA

Latest:

Long-Term Health Care Costs Following COVID-19: Implications for Pandemic Preparedness

A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.


Claudia Uribe, MD

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Jonathan Arnold, MD, MS, MSE

Latest:

Empiric Segmentation of High-risk Patients: A Structured Literature Review

Data-driven segmentation of high-risk patient populations may inform health system interventions, but results are dependent on the data sources and methods applied.


Megan Peter, PhD

Latest:

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.


Johnie Rose, MD, PhD

Latest:

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.


Jennifer Baron
Jennifer Baron

Latest:

Contributor: In a Fast-Growing and Competitive Dual-Eligible Market, Trust Will Be a Critical Differentiator

Building trust with patients who are dually eligible for Medicaid and Medicare can help to improve their lives as they navigate receiving care to address their clinical and behavioral health needs.


Crystal Harris, MPH

Latest:

Considerations to Increase Rates of Breast Cancer Screening Across Populations

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.


Osayande Osagiede, MBBS, MPH

Latest:

Impact of Travel Distance on Quality Outcomes in Colorectal Cancer

This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.


Chad Stecher, PhD

Latest:

Cost Savings From an mHealth Tool for Improving Medication Adherence

The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.


H. Shelton Brown, PhD

Latest:

Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.


Ninfa Candela, MD

Latest:

Outcomes in Patients With IBD Stratified by Risk of Disease Progression

This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.


Andrei Racila, BS

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Zahoor Elahi, MS

Latest:

Machine Intelligence for Early Targeted Precision Management and Response to Outbreaks of Respiratory Infections

This paper evaluates novel machine intelligence to predict patients at risk of severe respiratory infections and recommend postacute care providers likely to reduce infection risk.


Pelin Ozluk, PhD

Latest:

Trends in Low-Value Cancer Care During the COVID-19 Pandemic

Among adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.


Ahmed Shelbaya, MD

Latest:

Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.


Ambrose Panico, DO

Latest:

Contributor: The Connection Between Gout and CVD Requires Cross-Specialty Collaboration

The Panicos are on a mission to change how we think about gout. Why? As a husband-and-wife DO duo, the Panicos each have a unique perspective on gout and how physicians in their respective fields can better collaborate to help patients who live with this systemic disease.


Aaron Kofner, MS

Latest:

Differences in Telehealth During COVID-19 Between Commercial and Medicaid Enrollees

Differences in use of telehealth between commercial and Medicaid populations during the COVID-19 pandemic are associated with managed care enrollment.


Jeffrey Skolnick, MD

Latest:

How DNA Medicines Could Transform Treatment of Glioblastoma Multiforme

Better technology is rekindling the promise of DNA medicines in oncology, including the treatment of glioblastoma.


Winnie Chi, PhD

Latest:

Social Determinants of Health and High-Cost Utilization Among Commercially Insured Population

Residence in a more disadvantaged neighborhood was associated with higher likelihood of being a high-cost utilizer among older adults and lower likelihood among younger adults.


Gabriela Dieguez, MSc

Latest:

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.


Janine Bera, MD

Latest:

Improving System-Based Tobacco Cessation in a Community Health Clinic

This case study demonstrates how system-based tobacco cessation was enhanced in a community clinic.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.